Profile data is unavailable for this security.
About the company
Jiangsu Yahong Meditech Co Ltd is a China-based company primarily engaged in innovative drugs in the fields of urogenital system tumors and women's health. The Company's product pipeline in women's health, breast cancer, and gynecologic oncology includes APL-1702, APL-2302, and APL-2501. Products in the field of urological oncology include contrast agents that assist in the diagnosis or surgery of bladder cancer, APL-1202/APL-1501, and APL-2401. Products in other disease areas include APL-1401 for ulcerative colitis, APL-2301 for treating infections caused by Acinetobacter baumannii, and APL-1202 for treating Entamoeba histolytica infections.
- Revenue in CNY (TTM)279.02m
- Net income in CNY-362.17m
- Incorporated2010
- Employees391.00
- LocationJiangsu Yahong Meditech Co Ltd19F, Building B,Qiantan World Trade CentLane 221, Dongyu Road, Pudong New AreaSHANGHAI 200126ChinaCHN
- Phone+86 2 168585280
- Fax+86 2 168585281
- Websitehttps://www.asieris.cn/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Qingdao Vland Biotech INC | 1.39bn | 83.57m | 3.96bn | 1.57k | 47.54 | 2.23 | -- | 2.85 | 0.329 | 0.329 | 5.50 | 7.01 | 0.4585 | 3.89 | 3.65 | -- | 3.76 | 4.84 | 6.11 | 6.94 | 44.19 | 45.52 | 8.20 | 9.54 | 0.877 | -- | 0.2648 | 32.35 | 10.16 | 9.30 | -22.39 | -4.23 | -2.71 | -6.89 |
| Hinova Pharmaceuticals Inc | 23.61m | -144.57m | 4.47bn | 173.00 | -- | 4.06 | -- | 189.15 | -1.46 | -1.46 | 0.2384 | 11.12 | 0.0171 | 2.37 | 5.59 | 136,467.70 | -10.45 | -26.09 | -11.68 | -29.74 | 95.50 | -- | -612.36 | -78,863.60 | 6.90 | -- | 0.0883 | -- | -- | -38.67 | 32.18 | -- | 139.77 | -- |
| Shanghai Aladdin Biochemical Tech Co Ltd | 599.98m | 83.95m | 5.28bn | 652.00 | 63.82 | 4.95 | -- | 8.79 | 0.2485 | 0.2485 | 1.78 | 3.21 | 0.2785 | 0.4218 | 4.55 | 920,216.30 | 5.04 | 7.81 | 6.90 | 8.60 | 62.21 | 60.61 | 18.09 | 24.95 | 1.53 | 9.15 | 0.3541 | 48.33 | 32.44 | 20.55 | 15.07 | 9.17 | 41.61 | -- |
| Hangzhou Alltest Biotech Co Ltd | 881.63m | 294.76m | 5.41bn | 969.00 | 18.33 | 1.39 | -- | 6.14 | 3.72 | 3.72 | 11.12 | 49.21 | 0.2098 | 2.38 | 6.39 | 909,839.10 | 7.02 | 19.18 | 7.57 | 21.66 | 55.00 | 57.79 | 33.47 | 38.82 | 8.34 | -- | 0.0093 | 35.14 | 14.83 | 29.13 | 67.50 | 30.99 | 71.01 | -- |
| Bide Pharmatech Co Ltd | 1.27bn | 153.31m | 5.43bn | 738.00 | 33.98 | 2.71 | -- | 4.27 | 1.76 | 1.76 | 14.49 | 22.03 | 0.5167 | 0.8804 | 5.25 | 1,720,520.00 | 6.24 | 7.02 | 7.52 | 8.29 | 43.30 | 42.16 | 12.07 | 13.13 | 2.78 | -- | 0.1055 | 48.73 | 0.9298 | 34.69 | 7.17 | -- | 80.65 | -- |
| Shouyao Holdings Co Ltd | 2.14m | -206.73m | 5.78bn | 178.00 | -- | 8.83 | -- | 2,697.32 | -1.39 | -1.39 | 0.0144 | 4.40 | 0.0025 | 0.0366 | 0.2625 | 12,033.88 | -23.67 | -32.53 | -27.20 | -36.25 | 95.74 | 99.43 | -9,651.03 | -3,370.01 | 6.42 | -- | 0.0044 | -- | -24.61 | -19.34 | -14.21 | -- | 49.71 | -- |
| Jiangsu Yahong Meditech Co Ltd | 279.02m | -362.17m | 6.84bn | 391.00 | -- | 3.86 | -- | 24.52 | -0.642 | -0.642 | 0.4933 | 3.10 | 0.125 | 11.16 | 4.19 | 713,603.90 | -16.84 | -14.30 | -19.15 | -15.01 | 72.22 | 73.78 | -134.65 | -703.80 | 4.96 | -- | 0.1545 | -- | 1,365.55 | -- | 4.09 | -- | 50.48 | -- |
| GemPharmatech Co Ltd | 752.70m | 121.51m | 6.98bn | 1.58k | 56.61 | 3.17 | -- | 9.27 | 0.3007 | 0.3007 | 1.86 | 5.37 | 0.2807 | 4.51 | 1.88 | 476,993.40 | 4.53 | 7.69 | 5.42 | 8.96 | 61.84 | 68.17 | 16.14 | 25.58 | 3.17 | -- | 0.1295 | 21.94 | 10.39 | 28.94 | -30.89 | 25.88 | 20.02 | -- |
| Beijing Sun-Novo Pharma Research Co Ltd | 1.02bn | 133.01m | 7.46bn | 1.36k | 54.87 | 6.42 | -- | 7.34 | 1.21 | 1.21 | 9.23 | 10.38 | 0.4745 | 35.48 | 1.28 | 653,956.40 | 6.04 | 11.39 | 10.49 | 18.82 | 48.60 | 53.31 | 12.72 | 19.66 | 1.78 | 9.97 | 0.3355 | 11.29 | 15.70 | 35.80 | -3.98 | 30.21 | 3.50 | -- |
| Shanghai Medicilon Inc | 1.08bn | -231.86m | 8.93bn | 2.27k | -- | 4.33 | -- | 8.27 | -1.75 | -1.75 | 8.04 | 15.36 | 0.3759 | 8.56 | 1.68 | 459,338.00 | -8.08 | 3.66 | -9.99 | 4.63 | 16.27 | 31.15 | -21.49 | 6.67 | 2.19 | -- | 0.1508 | 40.97 | -24.01 | 18.22 | -896.21 | -- | 2.54 | -- |
Data as of Feb 13 2026. Currency figures normalised to Jiangsu Yahong Meditech Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
5.28%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Penghua Fund Management Co., Ltd.as of 30 Jun 2025 | 9.74m | 3.45% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2025 | 2.07m | 0.73% |
| Guotai Asset Management Co., Ltd.as of 30 Jun 2025 | 881.87k | 0.31% |
| Zhong Ou Asset Management Co., Ltdas of 30 Jun 2025 | 559.38k | 0.20% |
| AXA-SPDB Investment Managers Co., Ltd.as of 30 Jun 2025 | 321.99k | 0.11% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2025 | 317.07k | 0.11% |
| China Life AMP Asset Management Co., Ltd.as of 30 Jun 2025 | 300.00k | 0.11% |
| New China Fund Management Co., Ltd.as of 30 Jun 2025 | 277.81k | 0.10% |
| Shanghai Guotai Junan Securities Assets Management Co., Ltd.as of 30 Jun 2025 | 249.43k | 0.09% |
| Huatai-PineBridge Fund Management Co., Ltd.as of 30 Jun 2025 | 220.52k | 0.08% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
